Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Obesity-associated inflammation promotes angiogenesis and breast cancer via angiopoietin-like 4.

Authors: Kolb, Ryan; Kluz, Paige; Tan, Zhen Wei; Borcherding, Nicholas; Bormann, Nicholas; Vishwakarma, Ajaykumar; Balcziak, Louis; Zhu, Pengcheng; Davies, Brandon Sj; Gourronc, Francoise; Liu, Ling-Zhi; Ge, Xin; Jiang, Bing-Hua; Gibson-Corley, Katherine; Klingelhutz, Aloysius; Tan, Nguan Soon; Zhu, Yuwen; Sutterwala, Fayyaz S; Shen, Xian; Zhang, Weizhou

Published In Oncogene, (2019 03)

Abstract: Obesity is a risk factor for breast cancer and also predicts poor clinical outcomes regardless of menopausal status. Contributing to the poor clinical outcomes is the suboptimal efficacy of standard therapies due to dose limiting toxicities and obesity-related complications, highlighting the need to develop novel therapeutic approaches for treating obese patients. We recently found that obesity leads to an increase in tumor-infiltrating macrophages with activated NLRC4 inflammasome and increased interleukin (IL)-1β production. IL-1β, in turn, leads to increased angiogenesis and cancer progression. Using Next Generation RNA sequencing, we identified an NLRC4/IL-1β-dependent upregulation of angiopoietin-like 4 (ANGPTL4), a known angiogenic factor in cancer, in tumors from obese mice. ANGPTL4-deficiency by genetic knockout or treatment with a neutralizing antibody led to a significant reduction in obesity-induced angiogenesis and tumor growth. At a mechanistic level, ANGPTL4 expression is induced by IL-1β from primary adipocytes in a manner dependent on NF-κB- and MAP kinase-activation, which is further enhanced by hypoxia. This report shows that adipocyte-derived ANGPTL4 drives disease progression under obese conditions and is a potential therapeutic target for treating obese breast cancer patients.

PubMed ID: 30518876 Exiting the NIEHS site

MeSH Terms: Angiopoietin-Like Protein 4/genetics; Angiopoietin-Like Protein 4/physiology*; Animals; Breast Neoplasms/blood supply; Breast Neoplasms/genetics; Breast Neoplasms/pathology*; Cells, Cultured; Disease Progression; Female; Humans; Inflammasomes/physiology; Inflammation/etiology; Inflammation/genetics; Inflammation/metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Mice, Obese; Neovascularization, Pathologic*/genetics; Neovascularization, Pathologic*/metabolism; Neovascularization, Pathologic*/pathology; Obesity/complications*; Obesity/genetics; Obesity/metabolism; Obesity/pathology

to Top